Bryan Townsend
- Democratic
- Senator
- District 11
Primary
This Bill adds 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) to Schedule I of the Uniform Controlled Substances Act. U-47700, also known as “Pink,” is a synthetic opioid recently encountered by law enforcement and public health officials and is being abused for its opioid properties. It is available over the Internet and is marketed as a “research chemical.” The safety risks to users are significant and the public health risks include large numbers of drug treatment admissions, emergency room visits and fatal overdoses. On November 14, 2016, the Federal Drug Enforcement Agency temporarily placed U-47700 in Schedule I for a two-year period, finding that this synthetic opioid has a high potential for abuse, no currently accepted medical use in treatment in the United States and lacks accepted safety for use under medical supervision. By Emergency Order dated December 15, 2016, the Secretary of State temporarily placed U-47700 in Schedule I. This Order is effective for 120 days. The permanent addition of U-47700 to Schedule I is required in the interest of public protection.
Signed by Governor
Passed By House. Votes: 40 YES 1 ABSENT
Reported Out of Committee (Health & Human Development) in House with 9 On Its Merits
Assigned to Health & Human Development Committee in House
Passed By Senate. Votes: 20 YES 1 ABSENT
Passed By Senate. Votes: 20 YES 1 ABSENT
Reported Out of Committee (Health, Children & Social Services) in Senate with 3 On Its Merits
Introduced and Assigned to Health, Children & Social Services Committee in Senate
| Bill Text Versions | Format |
|---|---|
| Bill Text | HTML PDF |
| Document | Format |
|---|---|
| No related documents. |
Data on Open States is updated periodically throughout the day from the official website of the Delaware General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.